Mark Rochman
Impact in
- Immunology top 5%
- IL-33, ST2, and ILC Pathways
- Immune Cell Function and Interaction
- Rheumatology top 2%
- Eosinophilic Disorders and Syndromes
Papers in
- Surgery 32
- Eosinophilic Esophagitis 32
- Immunology 20
- IL-33, ST2, and ILC Pathways 18
- Galectins and Cancer Biology 2
- Co-authors
- Marc E. Rothenberg (34 shared papers)Julie M. Caldwell (23 shared papers)Michael Bustin (11 shared papers)Jeffrey K. Rymer (4 shared papers)Jared Travers (6 shared papers)Nurit P. Azouz (3 shared papers)Cédric Malicet (4 shared papers)Emily M. Stucke (4 shared papers)
- Journals
- Journal of Allergy and Clinical Immunology (12 papers)Nature Communications (4 papers)JCI Insight (4 papers)Mucosal Immunology (3 papers)Molecular and Cellular Biology (2 papers)
- Partner nations
- United StatesIsraelGermany
In The Last Decade
Mark Rochman
51 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 99
- Immunology 620
- Rheumatology 404
- Surgery 866
- Immunology and Allergy 107
- Molecular Biology 542
Countries citing papers authored by Mark Rochman
This map shows the geographic impact of Mark Rochman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Rochman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Rochman more than expected).
Fields of papers citing papers by Mark Rochman
This network shows the impact of papers produced by Mark Rochman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Rochman. The network helps show where Mark Rochman may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Rochman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 142 | |
| 2 | 2016 | 129 | |
| 3 | 2015 | 105 | |
| 4 | 2018 | 97 | |
| 5 | 2013 | 95 | |
| 6 | 2009 | 91 | |
| 7 | 2017 | 80 | |
| 8 | 2018 | 79 | |
| 9 | 2017 | 68 | |
| 10 | 2013 | 61 | |
| 11 | 2010 | 61 | |
| 12 | 2001 | 57 | |
| 13 | 2022 | 54 | |
| 14 | 2021 | 52 | |
| 15 | 2002 | 43 | |
| 16 | 2014 | 41 | |
| 17 | 2010 | 40 | |
| 18 | 2017 | 39 | |
| 19 | 2020 | 38 | |
| 20 | 2011 | 36 |
About Mark Rochman
Mark Rochman is a scholar working on Surgery, Immunology, Molecular Biology, Rheumatology and Cancer Research, having authored 52 papers that have together received 1.9k indexed citations. Recurring topics across this work include Eosinophilic Esophagitis (32 papers), IL-33, ST2, and ILC Pathways (18 papers), Eosinophilic Disorders and Syndromes (12 papers), Genomics and Chromatin Dynamics (11 papers), RNA Research and Splicing (8 papers), RNA and protein synthesis mechanisms (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Galectins and Cancer Biology (2 papers). The work is most often cited by research in Immunology (620 citations), Rheumatology (404 citations), Surgery (866 citations), Immunology and Allergy (107 citations) and Molecular Biology (542 citations). Mark Rochman has collaborated with scholars based in United States, Israel and Germany. Frequent co-authors include Marc E. Rothenberg, Julie M. Caldwell, Michael Bustin, Jeffrey K. Rymer, Jared Travers, Nurit P. Azouz, Cédric Malicet, Emily M. Stucke, Ting Wen and Leah C. Kottyan. Their work appears in journals such as Journal of Allergy and Clinical Immunology, Nature Communications, JCI Insight, Mucosal Immunology and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.